CompanyCore
UK company intelligence
Company profile report
Prepared 09 June 2026

SHIRE US INVESTMENTS

06275900 · private-unlimited · incorporated 2007-06-11

1. Company facts

Status
dissolved
Lifecycle
⚰️ Wound down — Dissolved, in liquidation, or being struck off.
Jurisdiction
england-wales
Registered office
1 Kingdom Street, London, W2 6BD, United Kingdom
SIC codes
82990 — Other business support service activities n.e.c.
Accounts next due
Confirmation statement next due

2. Directors (2 active)

CHARSLEY, Sarah Lucy
director · appointed 2019-02-28 · born 12/1974 (age 52)
GIBBONS, Mark
director · appointed 2019-02-28 · born 1/1984 (age 42)

3. Shareholders (1 active)

Takeda Pharmaceutical Company Limited
75-100% shares · 75-100% voting · board control

4. Group structure

Takeda Pharmaceutical Company Limited is the ultimate parent — holding 75%+ shares. This company sits inside their group.

Takeda Pharmaceutical Company Limited
Corporate parent · 75-100%

Headline verdict

Opportunity score
55/100 (Worth a look)
Owner dependency
moderate — 58/100
Red flags
1 high · 0 medium · 0 low